Global Spectral Computed Tomography Market- Industry Analysis and Forecast (2019-2027) – By Application, End User, and Region.

Global Spectral Computed Tomography Market- Industry Analysis and Forecast (2019-2027) – By Application, End User, and Region.

Market Scenario

Global Spectral Computed Tomography Market was valued at US$ XX Mn in 2019 and is expected to reach US$ 990.50 Mn by 2027, at a CAGR of 6.20 % during a forecast period.   Global Spectral Computed Tomography Market The report study has analyzed the revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers, and market disrupters in the report, and the same is reflected in our analysis. The spectral computed tomography helps to perform image acquisition and processing at multiple energy levels. It improves visualization for computed tomography and assists to enhance patient care. The computed tomography (CT) has a place of importance in the medical imaging sector. It provides medical imaging solutions through the development of spectral imaging, which is the next phase of the evolution of computed tomography. Global Spectral Computed Tomography Market, Dynamics: Technological development, digitalization, and the use of artificial intelligence have fundamentally transformed the healthcare sector. The application area of the spectral computed tomography includes definitive identification of gout and detection of the different types of kidney stones to better guide its treatment, metal artifact reduction, and clear metal artifact reduction. The spectral computed tomography helps in vascular image interpretation, mainly in vessels or in the presence of thrombus. Some of the many key players are focusing on additional applications and investment in the technology of its usage in next-generation computed tomography diagnostics in the future. For instance, Philips Healthcare has made its prominence in the market for spectral technology and received FDA clearance for Spectral Diagnostic Suite. It provides a set of innovative visualization and analysis tools for its IQon Spectral technology. It also delivers enhanced spectral visualization and clinical applications capabilities. Global Spectral Computed Tomography Market, Segment Analysis: The Spectral computed tomography is also called dual-source or dual-energy CT). It is expected to become a major trend during the forecast period because of its potential. Almost, all the key players are focusing on the integration of spectral computed tomography. The Spectral computed tomography can break down X-ray photons with the help of chemical elements. It is based on visualization anatomy at different kV energies. It can be proficient with a dual-source CT scanner of an innovative method, which is used to switch between different energies during the scan and record kV levels during a scan. The spectral imaging computed tomography is bringing innovative clinical information to the diagnosis and categorization of many diseases. The computed tomography only has anatomical information in the units of tissue density, whereas the spectral imaging computed tomography brings additional contrast to the image, which helps to make subtle disease. It also brings the chemical composition to the diagnosis for the identification of the better characterizes the disease. The Hospital segment is expected to hold the supreme position in the global spectral computed tomography market. The dominant position in the market is attributed to the rise in the number of emergency admissions in hospitals and surgeries. The computed tomography is an impressive tool for the diagnosis of pre-operative and post-operative to identify the effectiveness of the treatment. An introduction of the spectral photon-counting computed tomography in the hospitals and clinics are mainly driven by image quality improvements, reduction in radiation exposure, and detection of conventional contrast media. Innovative scanner technology is expected to enable the search for the sensitive and specific combinations of SPCCT specific contrast media. Global Spectral Computed Tomography Market, Regional Analysis: North America region held the dominant position in 2019 and is projected to contribute a XX% share in the global spectral computed tomography market. The major market share is attributed to the presence of a huge patient population suffering from cardiovascular diseases and cancer. The presence of a well-developed healthcare sector and prominent healthcare service providers are also boosting regional growth. In America, there is some regulation for the usage of computed tomography. According to the new legislation, in the United States all CT scanners require to adhere to XR-29 standards for Medicare & Medicaid Services which includes the new MITA Smart-Dose standards of XR 29. It also includes four new feature requirements, which help computed tomography users to perform high-quality diagnostic imaging for patient safety. In the Asia Pacific region, the aging population, and a growing incidence of chronic diseases at a rapid rate are expected to contribute a XX% share in the global market growth. The rise in government spending on healthcare, private sector, and access to healthcare services across the developing nations is promising growth in the regional market. The Chinese government has made a strategy plan for healthcare and the establishment of a tiered healthcare system with its Healthy China 2030 strategy. Global Spectral Computed Tomography Market, Competitive Analysis: Some of the prominent key players are expanding capabilities of spectral computed tomography by integrating complementary technology like artificial intelligence (AI). The advanced AI-assisted technologies are expected to redefine the way of diagnosis and treatment of patients. In 2019, the Koninklijke Philips N.V. has stated the expansion of its radiology solutions with teleradiology services. The service contains the analysis of patients’ images from medical images taken from exams like X-ray exams, MR, and CT. In 2018, The Philips corporations have entered into a 15-year strategic partnership with ZorgSaam Hospital. The Philips has provided a wide range of diagnostic imaging and image-guided therapy solutions as per the agreement. The objective of the report is to present a comprehensive analysis of the Global Spectral Computed Tomography Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Spectral Computed Tomography Market dynamics, structure by analyzing the market segments and projects the Global Spectral Computed Tomography Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Spectral Computed Tomography Market make the report investor’s guide.

Scope of the Global Spectral Computed Tomography Market

Global Spectral Computed Tomography Market, By End User

• Diagnostic Centers • Hospitals & Clinics

Global Spectral Computed Tomography Market, By Application

• Oncology • Cardiology • Musculoskeletal Disorders • Diseases

Global Spectral Computed Tomography Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in Global Spectral Computed Tomography Market

• General Electric Company • Koninklijke Philips N.V • Hitachi Medical Corporation • Pie Medical Imaging • Shimadzu Corporation • Neusoft Medical Systems • Shenzhen Anke High-Tech Co., Ltd • Trivitron Healthcare • MARS Bioimaging Ltd • PerkinElmer Inc • Xoran Technologies • Varian Medical Systems • Toshiba Medical System Corporations • Philips Healthcare • Fisher Scientific • Bio-Rad Laboratories • Siemens

Table of Contents

Global Spectral Computed Tomography Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Spectral Computed Tomography Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Spectral Computed Tomography Market Analysis and Forecast 6.1. Spectral Computed Tomography Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Spectral Computed Tomography Market Analysis and Forecast, By End User 7.1. Introduction and Definition 7.2. Key Findings 7.3. Spectral Computed Tomography Market Value Share Analysis, By End User 7.4. Spectral Computed Tomography Market Size (US$ Mn) Forecast, By End User 7.5. Spectral Computed Tomography Market Analysis, By End User 7.6. Spectral Computed Tomography Market Attractiveness Analysis, By End User 8. Global Spectral Computed Tomography Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Spectral Computed Tomography Market Value Share Analysis, By Application 8.4. Spectral Computed Tomography Market Size (US$ Mn) Forecast, By Application 8.5. Spectral Computed Tomography Market Analysis, By Application 8.6. Spectral Computed Tomography Market Attractiveness Analysis, By Application 9. Global Spectral Computed Tomography Market Analysis, by Region 9.1. Spectral Computed Tomography Market Value Share Analysis, by Region 9.2. Spectral Computed Tomography Market Size (US$ Mn) Forecast, by Region 9.3. Spectral Computed Tomography Market Attractiveness Analysis, by Region 10. North America Spectral Computed Tomography Market Analysis 10.1. Key Findings 10.2. North America Spectral Computed Tomography Market Overview 10.3. North America Spectral Computed Tomography Market Value Share Analysis, By End User 10.4. North America Spectral Computed Tomography Market Forecast, By End User 10.4.1. Diagnostic Centers 10.4.2. Hospitals & Clinics 10.5. North America Spectral Computed Tomography Market Value Share Analysis, By Application 10.6. North America Spectral Computed Tomography Market Forecast, By Application 10.6.1. Oncology 10.6.2. Cardiology 10.6.3. Musculoskeletal Disorders 10.6.4. Diseases 10.7. North America Spectral Computed Tomography Market Value Share Analysis, by Country 10.8. North America Spectral Computed Tomography Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Spectral Computed Tomography Market Analysis, by Country 10.10. U.S. Spectral Computed Tomography Market Forecast, By End User 10.10.1. Diagnostic Centers 10.10.2. Hospitals & Clinics 10.11. U.S. Spectral Computed Tomography Market Forecast, By Application 10.11.1. Oncology 10.11.2. Cardiology 10.11.3. Musculoskeletal Disorders 10.11.4. Diseases 10.12. Canada Spectral Computed Tomography Market Forecast, By End User 10.12.1. Diagnostic Centers 10.12.2. Hospitals & Clinics 10.13. Canada Spectral Computed Tomography Market Forecast, By Application 10.13.1. Oncology 10.13.2. Cardiology 10.13.3. Musculoskeletal Disorders 10.13.4. Diseases 10.14. North America Spectral Computed Tomography Market Attractiveness Analysis 10.14.1. By End User 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Spectral Computed Tomography Market Analysis 11.1. Key Findings 11.2. Europe Spectral Computed Tomography Market Overview 11.3. Europe Spectral Computed Tomography Market Value Share Analysis, By End User 11.4. Europe Spectral Computed Tomography Market Forecast, By End User 11.4.1. Diagnostic Centers 11.4.2. Hospitals & Clinics 11.5. Europe Spectral Computed Tomography Market Value Share Analysis, By Application 11.6. Europe Spectral Computed Tomography Market Forecast, By Application 11.6.1. Oncology 11.6.2. Cardiology 11.6.3. Musculoskeletal Disorders 11.6.4. Diseases 11.7. Europe Spectral Computed Tomography Market Value Share Analysis, by Country 11.8. Europe Spectral Computed Tomography Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Spectral Computed Tomography Market Analysis, by Country 11.10. Germany Spectral Computed Tomography Market Forecast, By End User 11.10.1. Diagnostic Centers 11.10.2. Hospitals & Clinics 11.11. Germany Spectral Computed Tomography Market Forecast, By Application 11.11.1. Oncology 11.11.2. Cardiology 11.11.3. Musculoskeletal Disorders 11.11.4. Diseases 11.12. U.K. Spectral Computed Tomography Market Forecast, By End User 11.12.1. Diagnostic Centers 11.12.2. Hospitals & Clinics 11.13. U.K. Spectral Computed Tomography Market Forecast, By Application 11.13.1. Oncology 11.13.2. Cardiology 11.13.3. Musculoskeletal Disorders 11.13.4. Diseases 11.14. France Spectral Computed Tomography Market Forecast, By End User 11.14.1. Diagnostic Centers 11.14.2. Hospitals & Clinics 11.15. France Spectral Computed Tomography Market Forecast, By Application 11.15.1. Oncology 11.15.2. Cardiology 11.15.3. Musculoskeletal Disorders 11.15.4. Diseases 11.16. Italy Spectral Computed Tomography Market Forecast, By End User 11.16.1. Diagnostic Centers 11.16.2. Hospitals & Clinic 11.17. Italy Spectral Computed Tomography Market Forecast, By Application 11.17.1. Oncology 11.17.2. Cardiology 11.17.3. Musculoskeletal Disorders 11.17.4. Diseases 11.18. Spain Spectral Computed Tomography Market Forecast, By End User 11.18.1. Diagnostic Centers 11.18.2. Hospitals & Clinics 11.19. Spain Spectral Computed Tomography Market Forecast, By Application 11.19.1. Oncology 11.19.2. Cardiology 11.19.3. Musculoskeletal Disorders 11.19.4. Diseases 11.20. Rest of Europe Spectral Computed Tomography Market Forecast, By End User 11.20.1. Diagnostic Centers 11.20.2. Hospitals & Clinics 11.21. Rest of Europe Spectral Computed Tomography Market Forecast, By Application 11.21.1. Oncology 11.21.2. Cardiology 11.21.3. Musculoskeletal Disorders 11.21.4. Diseases 11.22. Europe Spectral Computed Tomography Market Attractiveness Analysis 11.22.1. By End User 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Spectral Computed Tomography Market Analysis 12.1. Key Findings 12.2. Asia Pacific Spectral Computed Tomography Market Overview 12.3. Asia Pacific Spectral Computed Tomography Market Value Share Analysis, By End User 12.4. Asia Pacific Spectral Computed Tomography Market Forecast, By End User 12.4.1. Diagnostic Centers 12.4.2. Hospitals & Clinics 12.5. Asia Pacific Spectral Computed Tomography Market Value Share Analysis, By Application 12.6. Asia Pacific Spectral Computed Tomography Market Forecast, By Application 12.6.1. Oncology 12.6.2. Cardiology 12.6.3. Musculoskeletal Disorders 12.6.4. Diseases 12.7. Asia Pacific Spectral Computed Tomography Market Value Share Analysis, by Country 12.8. Asia Pacific Spectral Computed Tomography Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Spectral Computed Tomography Market Analysis, by Country 12.10. China Spectral Computed Tomography Market Forecast, By End User 12.10.1. Diagnostic Centers 12.10.2. Hospitals & Clinics 12.11. China Spectral Computed Tomography Market Forecast, By Application 12.11.1. Oncology 12.11.2. Cardiology 12.11.3. Musculoskeletal Disorders 12.11.4. Diseases 12.12. India Spectral Computed Tomography Market Forecast, By End User 12.12.1. Diagnostic Centers 12.12.2. Hospitals & Clinics 12.13. India Spectral Computed Tomography Market Forecast, By Application 12.13.1. Oncology 12.13.2. Cardiology 12.13.3. Musculoskeletal Disorders 12.13.4. Diseases 12.14. Japan Spectral Computed Tomography Market Forecast, By End User 12.14.1. Diagnostic Centers 12.14.2. Hospitals & Clinics 12.15. Japan Spectral Computed Tomography Market Forecast, By Application 12.15.1. Oncology 12.15.2. Cardiology 12.15.3. Musculoskeletal Disorders 12.15.4. Diseases 12.16. ASEAN Spectral Computed Tomography Market Forecast, By End User 12.16.1. Diagnostic Centers 12.16.2. Hospitals & Clinics 12.17. ASEAN Spectral Computed Tomography Market Forecast, By Application 12.17.1. Oncology 12.17.2. Cardiology 12.17.3. Musculoskeletal Disorders 12.17.4. Diseases 12.18. Rest of Asia Pacific Spectral Computed Tomography Market Forecast, By End User 12.18.1. Diagnostic Centers 12.18.2. Hospitals & Clinics 12.19. Rest of Asia Pacific Spectral Computed Tomography Market Forecast, By Application 12.19.1. Oncology 12.19.2. Cardiology 12.19.3. Musculoskeletal Disorders 12.19.4. Diseases 12.20. Asia Pacific Spectral Computed Tomography Market Attractiveness Analysis 12.20.1. By End User 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Spectral Computed Tomography Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Spectral Computed Tomography Market Overview 13.3. Middle East & Africa Spectral Computed Tomography Market Value Share Analysis, By End User 13.4. Middle East & Africa Spectral Computed Tomography Market Forecast, By End User 13.4.1. Diagnostic Centers 13.4.2. Hospitals & Clinics 13.5. Middle East & Africa Spectral Computed Tomography Market Value Share Analysis, By Application 13.6. Middle East & Africa Spectral Computed Tomography Market Forecast, By Application 13.6.1. Oncology 13.6.2. Cardiology 13.6.3. Musculoskeletal Disorders 13.6.4. Diseases 13.7. Middle East & Africa Spectral Computed Tomography Market Value Share Analysis, by Country 13.8. Middle East & Africa Spectral Computed Tomography Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Spectral Computed Tomography Market Analysis, by Country 13.10. GCC Spectral Computed Tomography Market Forecast, By End User 13.10.1. Diagnostic Centers 13.10.2. Hospitals & Clinics 13.11. GCC Spectral Computed Tomography Market Forecast, By Application 13.11.1. Oncology 13.11.2. Cardiology 13.11.3. Musculoskeletal Disorders 13.11.4. Diseases 13.12. South Africa Spectral Computed Tomography Market Forecast, By End User 13.12.1. Diagnostic Centers 13.12.2. Hospitals & Clinics 13.13. South Africa Spectral Computed Tomography Market Forecast, By Application 13.13.1. Oncology 13.13.2. Cardiology 13.13.3. Musculoskeletal Disorders 13.13.4. Diseases 13.14. Rest of Middle East & Africa Spectral Computed Tomography Market Forecast, By End User 13.14.1. Diagnostic Centers 13.14.2. Hospitals & Clinics 13.15. Rest of Middle East & Africa Spectral Computed Tomography Market Forecast, By Application 13.15.1. Oncology 13.15.2. Cardiology 13.15.3. Musculoskeletal Disorders 13.15.4. Diseases 13.16. Middle East & Africa Spectral Computed Tomography Market Attractiveness Analysis 13.16.1. By End User 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Spectral Computed Tomography Market Analysis 14.1. Key Findings 14.2. South America Spectral Computed Tomography Market Overview 14.3. South America Spectral Computed Tomography Market Value Share Analysis, By End User 14.4. South America Spectral Computed Tomography Market Forecast, By End User 14.4.1. Diagnostic Centers 14.4.2. Hospitals & Clinics 14.5. South America Spectral Computed Tomography Market Value Share Analysis, By Application 14.6. South America Spectral Computed Tomography Market Forecast, By Application 14.6.1. Oncology 14.6.2. Cardiology 14.6.3. Musculoskeletal Disorders 14.6.4. Diseases 14.7. South America Spectral Computed Tomography Market Value Share Analysis, by Country 14.8. South America Spectral Computed Tomography Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Spectral Computed Tomography Market Analysis, by Country 14.10. Brazil Spectral Computed Tomography Market Forecast, By End User 14.10.1. Diagnostic Centers 14.10.2. Hospitals & Clinics 14.11. Brazil Spectral Computed Tomography Market Forecast, By Application 14.11.1. Oncology 14.11.2. Cardiology 14.11.3. Musculoskeletal Disorders 14.11.4. Diseases 14.12. Mexico Spectral Computed Tomography Market Forecast, By End User 14.12.1. Diagnostic Centers 14.12.2. Hospitals & Clinics 14.13. Mexico Spectral Computed Tomography Market Forecast, By Application 14.13.1. Oncology 14.13.2. Cardiology 14.13.3. Musculoskeletal Disorders 14.13.4. Diseases 14.14. Rest of South America Spectral Computed Tomography Market Forecast, By End User 14.14.1. Diagnostic Centers 14.14.2. Hospitals & Clinics 14.15. Rest of South America Spectral Computed Tomography Market Forecast, By Application 14.15.1. Oncology 14.15.2. Cardiology 14.15.3. Musculoskeletal Disorders 14.15.4. Diseases 14.16. South America Spectral Computed Tomography Market Attractiveness Analysis 14.16.1. By End User 14.16.2. By Application 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.4. M&A by Regions, Investment and Applications 15.2.5. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. General Electric Company 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. End User Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Koninklijke Philips N.V 15.3.3. Hitachi Medical Corporation 15.3.4. Pie Medical Imaging 15.3.5. Shimadzu Corporation 15.3.6. Neusoft Medical Systems 15.3.7. Shenzhen Anke High-Tech Co., Ltd 15.3.8. Trivitron Healthcare 15.3.9. MARS Bioimaging Ltd 15.3.10. PerkinElmer Inc 15.3.11. Xoran Technologies 15.3.12. Varian Medical Systems 15.3.13. Toshiba Medical System Corporations 15.3.14. Philips Healthcare 15.3.15. Fisher Scientific 15.3.16. Bio-Rad Laboratories 15.3.17. Siemens

About This Report

Report ID67036
Category Healthcare
Published DateJuly 2020
No of Pages178
Contact Us
Call Now